Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 8580475, 9 pages
http://dx.doi.org/10.1155/2016/8580475
Research Article

Renal Ischemia/Reperfusion Injury in Diabetic Rats: The Role of Local Ischemic Preconditioning

1Department of Anesthesiology and Reanimation, School of Medicine, Dokuz Eylul University, Izmir, Turkey
2Department of General Surgery, School of Medicine, Dokuz Eylul University, Izmir, Turkey
3Department of Histology and Embryology, School of Medicine, Dokuz Eylul University, Izmir, Turkey
4Department of Experienced Laboratory Animal Science, School of Medicine, Dokuz Eylul University, Izmir, Turkey
5Department of Nutrition and Dietetics, Izmir Ataturk School of Health, Ege University, Izmir, Turkey

Received 3 November 2015; Revised 22 December 2015; Accepted 4 January 2016

Academic Editor: Jeremiah R. Brown

Copyright © 2016 Sule Ozbilgin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. R. Nolan and R. W. Schrier, “Kidney in hypertension,” in Renal and Electrolyte Disorders, R. W. Schrier, Ed., pp. 272–324, Williams & Wilkins Lippincott, Philadelphia, Pa, USA, 6th edition, 2005. View at Google Scholar
  2. M. D. Oldfield and M. E. Cooper, “The biochemistry and pathophysiology of renal lesions in type 2 diabetes,” in Diabetic Nephropathy in Type 2 Diyabetes, C. E. Mogensen, Ed., pp. 41–56, Science Press, London, UK, 1st edition, 2002. View at Google Scholar
  3. P. Maisonneuve, L. Agodoa, R. Gellert et al., “Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study,” American Journal of Kidney Diseases, vol. 35, no. 1, pp. 157–165, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Shi, D. Patschan, T. Epstein, M. S. Goligorsky, and J. Winaver, “Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury,” American Journal of Physiology—Renal Physiology, vol. 293, no. 5, pp. F1512–F1517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Woodrow, A. M. Brownjohn, and J. H. Turney, “Acute renal failure in patients with type 1 diabetes mellitus,” Postgraduate Medical Journal, vol. 70, no. 821, pp. 192–194, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Mejía-Vilet, V. Ramírez, C. Cruz, N. Uribe, G. Gamba, and N. A. Bobadilla, “Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone,” The American Journal of Physiology—Renal Physiology, vol. 293, no. 1, pp. F78–F86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. S. T. Yuen, S.-K. Jo, M. K. Holly, X. Hu, and R. A. Star, “Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses,” Physiological Genomics, vol. 25, no. 3, pp. 375–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Mejía-Vilet, V. Ramírez, C. Cruz, N. Uribe, G. Gamba, and N. A. Bobadilla, “Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone,” American Journal of Physiology: Renal Physiology, vol. 293, no. 1, pp. F78–F86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Bagcik, S. Ozkardesler, N. Boztas et al., “Effects of dexmedetomidine in conjunction with remote ischemic preconditioning on renal ischemia-reperfusion injury in rats,” Revista Brasileira de Anestesiologia, vol. 64, no. 6, pp. 382–390, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Mishra, C. Dent, R. Tarabishi et al., “Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery,” The Lancet, vol. 365, no. 9466, pp. 1231–1238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Haase, R. Bellomo, P. Devarajan et al., “Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis,” American Journal of Kidney Diseases, vol. 54, no. 6, pp. 1012–1024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Guneli, K. Tugyan, H. Ozturk, M. Gumustekin, S. Cilaker, and N. Uysal, “Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats,” European Surgical Research, vol. 40, no. 4, pp. 354–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Satman, T. Yilmaz, A. Sengul et al., “Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP),” Diabetes Care, vol. 25, no. 9, pp. 1551–1556, 2002. View at Google Scholar
  15. W. H. Herman, “Eye disease and nephropathy in NIDDM,” Diabetes Care, vol. 13, no. 2, pp. 24–29, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-P. Zhou, W.-T. Liao, L.-K. Yang, and L. Sun, “Effects of sevoflurane pretreatment on renal Src and FAK expression in diabetic rats after renal ischemia/reperfusion injury,” Molecular and Cellular Biochemistry, vol. 384, no. 1-2, pp. 203–211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Fouad, A. S. Al-Mulhim, I. Jresat, and M. A. Morsy, “Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury,” Journal of Pharmacy and Pharmacology, vol. 65, no. 2, pp. 243–252, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Kuramochi and S. Homma, “Effects of furosemide on renal oxygen consumption after ischemia in normal and streptozotocin diabetic rats,” Nephron, vol. 64, no. 3, pp. 436–442, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Wald, H. Markowitz, S. Zevin, and M. M. Popovtzer, “Opposite effects of diabetes on nephrotoxic and ischemic acute tubular necrosis,” Proceedings of the Society for Experimental Biology and Medicine, vol. 195, no. 1, pp. 51–56, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Abu-Saleh, E. Ovcharenko, H. Awad et al., “Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model,” Life Sciences, vol. 91, no. 13-14, pp. 669–675, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. C. Mıcılı, B. U. Ergur, C. Ozoğul et al., “Effects of lipoic acid in an experimentally induced hypertensive and diabetic rat model,” Clinical and Experimental Hypertension, vol. 35, no. 5, pp. 373–381, 2012. View at Publisher · View at Google Scholar
  22. J. Zhu, X. Chen, H. Wang, and Q. Yan, “Catalpol protects mice against renal ischemia/reperfusion injury via suppressing PI3K/Akt-eNOS signaling and inflammation,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 2, pp. 2038–2044, 2015. View at Google Scholar
  23. S.-S. Huang, F.-C. Wei, and L.-M. Hung, “Ischemic preconditioning attenuates postischemic leukocyte-endothelial cell interactions—role of nitric oxide and protein kinase C,” Circulation Journal, vol. 70, no. 8, pp. 1070–1075, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Gill, J. V. Nally Jr., and R. A. Fatica, “Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management,” Chest, vol. 128, no. 4, pp. 2847–2863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. E. Wever, T. P. Menting, M. Rovers et al., “Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis,” PLoS ONE, vol. 7, no. 2, Article ID e32296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Kocoglu, H. Ozturk, H. Ozturk, F. Yilmaz, and N. Gulcu, “Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a Histopathologic study,” Renal Failure, vol. 31, no. 1, pp. 70–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. P. D. Williams, H. Lopez, D. Britt, C. Chan, A. Ezrin, and R. Hottendorf, “Characterization of renal ischemia-reperfusion injury in rats,” Journal of Pharmacological and Toxicological Methods, vol. 37, no. 1, pp. 1–7, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kou, R. Li, Y. Zhou et al., “The intermediate and the differential receptor expression on renal ischemia/reperfusion rats,” The Journal of Medical Research, vol. 38, pp. 25–28, 2009. View at Google Scholar
  29. C. E. Murry, R. B. Jennings, and K. A. Reimer, “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium,” Circulation, vol. 74, no. 5, pp. 1124–1136, 1986. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Wolfrum, J. Nienstedt, M. Heidbreder, K. Schneider, P. Dominiak, and A. Dendorfer, “Calcitonin gene related peptide mediates cardioprotection by remote preconditioning,” Regulatory Peptides, vol. 127, no. 1–3, pp. 217–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. K. McCafferty, S. Forbes, C. Thiemermann, and M. M. Yaqoob, “The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities,” Disease Models and Mechanisms, vol. 7, no. 12, pp. 1321–1333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Mishra, M. A. Qing, A. Prada et al., “Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534–2543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. T. L. Nickolas, J. Barasch, and P. Devarajan, “Biomarkers in acute and chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 17, no. 2, pp. 127–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Kjeldsen, A. H. Johnsen, H. Sengelov, and N. Borregaard, “Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase,” Journal of Biological Chemistry, vol. 268, no. 14, pp. 10425–10432, 1993. View at Google Scholar · View at Scopus